These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 16360963)

  • 1. Atorvastatin therapy increases heart rate variability, decreases QT variability, and shortens QTc interval duration in patients with advanced chronic heart failure.
    Vrtovec B; Okrajsek R; Golicnik A; Ferjan M; Starc V; Radovancevic B
    J Card Fail; 2005 Dec; 11(9):684-90. PubMed ID: 16360963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin therapy shortens QTc, QTcd, and improves cardiac function in patients with chronic heart failure.
    Xie RQ; Cui W; Liu F; Yang C; Pei WN; Lu JC
    Int J Cardiol; 2010 Apr; 140(2):255-7. PubMed ID: 19042044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atorvastatin therapy may reduce the incidence of sudden cardiac death in patients with advanced chronic heart failure.
    Vrtovec B; Okrajsek R; Golicnik A; Ferjan M; Starc V; Schlegel TT; Radovancevic B
    J Card Fail; 2008 Mar; 14(2):140-4. PubMed ID: 18325461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in autonomic control of heart rate after ischemic cerebral stroke].
    Lakusić N; Mahović D; Babić T; Sporis D
    Acta Med Croatica; 2003; 57(4):269-73. PubMed ID: 14639860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of atorvastatin on ventricular late potentials and repolarization dispersion in patients with hypercholesterolemia.
    Chu CS; Lee KT; Lee ST; Lu YH; Lin TH; Voon WC; Sheu SH; Lai WT
    Kaohsiung J Med Sci; 2007 May; 23(5):217-24. PubMed ID: 17525003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of nesiritide (human b-type natriuretic peptide) and dobutamine on heart rate variability in decompensated heart failure.
    Aronson D; Burger AJ
    Am Heart J; 2004 Nov; 148(5):e16. PubMed ID: 15523294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholinergic stimulation with pyridostigmine reduces ventricular arrhythmia and enhances heart rate variability in heart failure.
    Behling A; Moraes RS; Rohde LE; Ferlin EL; Nóbrega AC; Ribeiro JP
    Am Heart J; 2003 Sep; 146(3):494-500. PubMed ID: 12947369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QT interval variability and adaptation to heart rate changes in patients with long QT syndrome.
    Nemec J; Buncová M; Shusterman V; Winter B; Shen WK; Ackerman MJ
    Pacing Clin Electrophysiol; 2009 Jan; 32(1):72-81. PubMed ID: 19140916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged QT interval and reduced heart rate variability in patients with uncomplicated essential hypertension.
    Maule S; Rabbia F; Perni V; Tosello F; Bisbocci D; Mulatero P; Veglio F
    Hypertens Res; 2008 Nov; 31(11):2003-10. PubMed ID: 19098371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD.
    Koren MJ; Davidson MH; Wilson DJ; Fayyad RS; Zuckerman A; Reed DP;
    Am J Kidney Dis; 2009 May; 53(5):741-50. PubMed ID: 19216014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diurnal pattern of QTc interval: how long is prolonged? Possible relation to circadian triggers of cardiovascular events.
    Molnar J; Zhang F; Weiss J; Ehlert FA; Rosenthal JE
    J Am Coll Cardiol; 1996 Jan; 27(1):76-83. PubMed ID: 8522713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effect of atorvastatin on neurohumoral activation and cardiac function in patients with chronic heart failure: a prospective randomized controlled study.
    Yamada T; Node K; Mine T; Morita T; Kioka H; Tsukamoto Y; Tamaki S; Masuda M; Okuda K; Fukunami M
    Am Heart J; 2007 Jun; 153(6):1055.e1-8. PubMed ID: 17540209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective evaluation of the effect of atazanavir on the QTc interval and QTc dispersion in HIV-positive patients.
    Busti AJ; Tsikouris JP; Peeters MJ; Das SR; Canham RM; Abdullah SM; Margolis DM
    HIV Med; 2006 Jul; 7(5):317-22. PubMed ID: 16945077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model.
    Kumagai K; Nakashima H; Saku K
    Cardiovasc Res; 2004 Apr; 62(1):105-11. PubMed ID: 15023557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged QTc interval and high B-type natriuretic peptide levels together predict mortality in patients with advanced heart failure.
    Vrtovec B; Delgado R; Zewail A; Thomas CD; Richartz BM; Radovancevic B
    Circulation; 2003 Apr; 107(13):1764-9. PubMed ID: 12665499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of posture and handgrip on the QT interval in left ventricular hypertrophy and in chronic heart failure.
    Davey P
    Clin Sci (Lond); 1999 Apr; 96(4):403-7. PubMed ID: 10087248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined atorvastatin and coenzyme Q10 improve the left ventricular function in isoproterenol-induced heart failure in rat.
    Garjani A; Andalib S; Biabani S; Soraya H; Doustar Y; Garjani A; Maleki-Dizaji N
    Eur J Pharmacol; 2011 Sep; 666(1-3):135-41. PubMed ID: 21570962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Literature review and pilot studies of the effect of QT correction formulas on reported beta2-agonist-induced QTc prolongation.
    Milic M; Bao X; Rizos D; Liu F; Ziegler MG
    Clin Ther; 2006 Apr; 28(4):582-90. PubMed ID: 16750469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of increased short-term variability of QT interval to congenital long-QT syndrome.
    Hinterseer M; Beckmann BM; Thomsen MB; Pfeufer A; Dalla Pozza R; Loeff M; Netz H; Steinbeck G; Vos MA; Kääb S
    Am J Cardiol; 2009 May; 103(9):1244-8. PubMed ID: 19406266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart rate variability, late potentials and QT dispersion as markers of myocardial involvement in patients with Behçet's disease.
    Kirimli O; Aslan O; Göldeli O; Güneri S; Badak O; Fetil E; Ozkan S
    Can J Cardiol; 2000 Mar; 16(3):345-51. PubMed ID: 10744798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.